DrugPatentWatch Database Preview
Investigational Drug Information for C1-INH
Email this page to a colleague
What is the development status for investigational drug C1-INH?
C1-INH is an investigational drug.
There have been 6 clinical trials for C1-INH.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 16th 2016.
The most common disease conditions in clinical trials are Wounds and Injuries, Reperfusion Injury, and Ischemia. The leading clinical trial sponsors are Universitaire Ziekenhuizen Leuven, CSL Behring, and NYU Langone Health.
There are seventeen US patents protecting this investigational drug and one hundred and forty international patents.
Summary for C1-INH
| US Patents | 17 |
| International Patents | 140 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2016-11-16) |
| Vendors | 0 |
Recent Clinical Trials for C1-INH
| Title | Sponsor | Phase |
|---|---|---|
| Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients | CSL Behring | Phase 3 |
| C1-inhibitor in Allergic ASThma Patients | Sanquin | Phase 4 |
| C1-inhibitor in Allergic ASThma Patients | Sanquin Plasma Products BV | Phase 4 |
Clinical Trial Summary for C1-INH
Top disease conditions for C1-INH
Top clinical trial sponsors for C1-INH
US Patents for C1-INH
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| C1-INH | ⤷ Sign up for a Free Trial | Compositions and methods useful for the treatment of neuromyelitis optica spectrum disorders | SHIRE VIROPHARMA INCORPORATED (Lexington, MA) | ⤷ Sign up for a Free Trial |
| C1-INH | ⤷ Sign up for a Free Trial | Protein biomarkers for immune assessment and prediction of transplant rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, CA) | ⤷ Sign up for a Free Trial |
| C1-INH | ⤷ Sign up for a Free Trial | Combination therapy using immunoglobulin and C1-Inhibitor | CSL BEHRING GMBH (Marburg, DE) THE GOVERNMENT OF THE UNITED STATES OF AMERICA (Rockville, MD) | ⤷ Sign up for a Free Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for C1-INH
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| C1-INH | Australia | AU2015243424 | 2034-04-09 | ⤷ Sign up for a Free Trial |
| C1-INH | Canada | CA2944990 | 2034-04-09 | ⤷ Sign up for a Free Trial |
| C1-INH | European Patent Office | EP3129781 | 2034-04-09 | ⤷ Sign up for a Free Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
